+91-22-45045900 sales@clearsynth.com
Reference Standard Product Detail
Home Reference Standard Ceritinib CS-O-11185

Ceritinib

Explore technical data, documentation access, molecular information and enquiry options for this Clearsynth research product.

Product Code: CS-O-11185 Reference Standard Research Use Only
Ceritinib
Category
Reference Standard
API Family
Ceritinib
Product Code
CS-O-11185
Research Status
For Laboratory Use

Ceritinib

Ceritinib Reference Standard
Stock Status: In Stock
Live

CAT No.
CS-O-11185
CAS No.
1032900-25-6
Molecular Formula
C28H36ClN5O3S
Molecular Weight
558.14
Login to view price
There is no hazardous surcharge associated with this product.
There is no packaging charge associated with this product.
For Research Purposes only. Not for Personal or Veterinary use.
All compounds supplied are strictly intended for laboratory, research, analytical, and scientific use only. They are not meant for human consumption, therapeutic use, or any form of clinical application.
CAS No.
1032900-25-6
Product Code
CS-O-11185
M.F.
C28H36ClN5O3S
M.W.
558.14
Smiles
O=S(C1=CC=CC=C1NC2=NC(NC3=CC(C)=C(C4CCNCC4)C=C3OC(C)C)=NC=C2Cl)(C(C)C)=O
Category
Reference Standard
API Family
Ceritinib
Storage Condition
Store at refrigerator (2-8°C) for long term storage
IUPAC Name
5-Chloro-N2-(2-isopropoxy-5-methyl-4-(piperidin-4-yl)phenyl)-N4-(2-(isopropylsulfonyl)phenyl)pyrimidine-2,4-diamine
References
"Medscape, April 29, 2014; Engelman JA (2014)"
Synonyms
5-Chloro-N2-(2-isopropoxy-5-methyl-4-(piperidin-4-yl)phenyl)-N4-(2-(isopropylsulfonyl)phenyl)pyrimidine-2,4-diamine
Application Notes
Ceritinib is used for the treatment of adults with anaplastic lymphoma kinase (ALK)-positive metastatic non-small cell lung cancer (NSCLC) following failure (secondary to resistance or intolerance) of prior crizotinib therapy.
Purity by HPLC
Not less than 95%
Hazard Compound
Refer MSDS for accurate information.
Overview
Ceritinib is used for the treatment of adults with anaplastic lymphoma kinase (ALK)-positive metastatic non-small cell lung cancer (NSCLC) following failure (secondary to resistance or intolerance) of prior crizotinib therapy.

Customers Also Viewed

N-Nitroso Ceritinib

N-Nitroso Ceritinib

CAT No: CS-O-51791
CAS No: NA

Refund Policy

We are committed to offering products of the highest quality in order to meet the needs of our customers, and have elaborate systems in place to ensure that material specifications, their certification and all handling and storage conditions are communicated at the time of material handover. We have invested in the highest quality packaging materials and use international logistics partners to service our customers. If there is an issue with one or more of our products, it must be reported to us within 45 days of your receiving shipment for refund or account credit eligibility.

Downloading MSDS…
Quick Enquiry Email Us
Quick Enquiry
Tell us what you need
Quote Basket
Selected RFQ Items
Your RFQ basket is empty. Add a product block or copy a guided requirement here.